Cancer Research AACR Membership  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 4507-4510, October 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, H.-S.
Right arrow Articles by Wright, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, H.-S.
Right arrow Articles by Wright, N. A.

The Incidence of Aberrant Crypt Foci and Colonic Carcinoma in Dimethylhydrazine-treated Rats Varies in a Site-specific Manner and Depends on Tumor Histology1

Hyun-Sook Park2, Robert A. Goodlad and Nicholas A. Wright

Department of Histopathology, Royal Postgraduate Medical School, Hammersmith Hospital, London W12, and Histopathology Unit, Imperial Cancer Research Fund, London WC2A, United Kingdom

In an attempt to demonstrate the relationship between aberrant crypt foci (ACF) and subsequent colonic neoplasms, we investigated the distribution of ACF in the dimethylhydrazine (DMH) model of colonic carcinogenesis in the rat. DMH was given to male Wistar rats by s.c. injection in a dosage of 15 mg/kg body weight once a week for 19 weeks. As a result, eight poorly differentiated, mucin-secreting carcinomas, two well-differentiated tubular adenocarcinomas, and four adenomas developed in 35 rats autopsied at 24 weeks after the first injection of DMH. The location of each type of tumor was site specific. Poorly differentiated, mucin-secreting carcinomas of signet-ring type occurred only in the proximal colon; the mean location of these lesions was 17.6 ± 3.8% (SE; range, 0–39%) of the length of the colon. Well-differentiated tubular adenocarcinomas and adenomas developed in the distal colon; the mean location of these lesions was 76.7% ± 4.9 (SE; range, 60–90%) of the length of the colon. These was a mean number of 276 ± 29 (SE) ACF per colon; these were present at between 40 and 90% of the colonic length, peaking at 70%. We conclude that ACF are marker lesions for colonic neoplasms, but only in the distal colon where tumors follow the adenoma-carcinoma sequence; this is not so for the proximal colon, where poorly differentiated, mucin-secreting carcinomas are found. These findings suggest that these latter tumors well may arise de novo and indicate that studies that attempt to correlate ACF with subsequent tumor formation must take cognizance, not only of the site, but also of the tumor type.

1 This work was supported by grants from the British Council and the Imperial Cancer Research Fund (to H-S. P.).

2 To whom requests for reprints should be addressed, at Histopathology Unit, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom. Phone: 44-(0)171-269-3425; Fax: 44-(0)171-269-3491; E-mail: park.icrf.icnet.uk.

Received 5/16/97. Accepted 8/15/97.




This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
L Ziliotto, L. Barbisan, and M. Rodrigues
Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci
Human and Experimental Toxicology, June 1, 2008; 27(6): 505 - 511.
[Abstract] [PDF]


Home page
Cancer Res.Home page
D. W.L. Ma, R. H. Finnell, L. A. Davidson, E. S. Callaway, O. Spiegelstein, J. A. Piedrahita, J. M. Salbaum, C. Kappen, B. R. Weeks, J. James, et al.
Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis
Cancer Res., February 1, 2005; 65(3): 887 - 897.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. R. Nambiar, M. Nakanishi, R. Gupta, E. Cheung, A. Firouzi, X.-J. Ma, C. Flynn, M. Dong, K. Guda, J. Levine, et al.
Genetic signatures of High- and Low-Risk Aberrant Crypt Foci in a Mouse Model of Sporadic Colon Cancer
Cancer Res., September 15, 2004; 64(18): 6394 - 6401.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. E. Jackson, P. J. O'Connor, D. P. Cooper, G. P. Margison, and A. C. Povey
Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine
Carcinogenesis, March 1, 2003; 24(3): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. C. Povey, A. F. Badawi, D. P. Cooper, C. N. Hall, K. L. Harrison, P. E. Jackson, N. P. Lees, P. J. O'Connor, and G. P. Margison
DNA Alkylation and Repair in the Large Bowel: Animal and Human Studies
J. Nutr., November 1, 2002; 132(11): 3518S - 3521.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. I. Salim, H. Wanibuchi, K. Morimura, T. Murai, S. Makino, T. Nomura, and S. Fukushima
Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)--modulation by long-chain fatty acids
Carcinogenesis, September 1, 2002; 23(9): 1519 - 1529.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Y Kishimoto, N Takata, T Jinnai, T Morisawa, G Shiota, H Kawasaki, and J Hasegawa
Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane
Gut, December 1, 2000; 47(6): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.M. Gee, H.P.J.M. Noteborn, A.C.J. Polley, and I.T. Johnson
Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein
Carcinogenesis, December 1, 2000; 21(12): 2255 - 2259.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Papanikolaou, Q.-S. Wang, D. Papanikolaou, H. E. Whiteley, and D. W. Rosenberg
Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis
Carcinogenesis, August 1, 2000; 21(8): 1567 - 1572.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. P. Soler, R.D. Miller, K. V. Laughlin, N. Z. Carp, D. M. Klurfeld, and J. M. Mullin
Increased tight junctional permeability is associated with the development of colon cancer
Carcinogenesis, August 1, 1999; 20(8): 1425 - 1432.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Latham, E. K. Lund, and I. T. Johnson
Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon
Carcinogenesis, April 1, 1999; 20(4): 645 - 650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.